Oncogene Amplification and Oncoprotein Overexpression in Superficial Esophageal Cancer

  • Mario Sarbia
Conference paper


The depth of tumor penetration is a crucial factor determining the prognosis of esophageal carcinoma patients [1,2]. Any carcinoma that extends no deeper than the submucosa is referred to as superficial esophageal carcinoma regardless of lymph node metastasis [3]. Patients with superficial esophageal carcinomas, especially those limited to the mucosa, have significantly more favorable outcome than those with advanced cancer. On the other hand, the risk of nodal metastasis of submucosal carcinomas is about 35%, and the prognosis of these patients does not differ significantly from that of patients with advanced carcinoma. Whereas the frequency of superficial esophageal carcinomas in Western countries is still low [4], in Japan, because of intensified screening, the rate of superficial cancer has been increasing in recent years [3]. Nevertheless, the features of superficial esophageal carcinoma, especially its molecular biologic aberrations, are poorly studied so far. In the current study we therefore investigated the frequency of oncogene amplification and oncoprotein overexpression in the two histological main types of esophageal cancer: squamous cell carcinoma (SCC) and adenocarcinoma (ADC). To determine if the molecular biology of superficial carcinoma differs significantly from that of advanced carcinoma, we compared our findings with a series of advanced esophageal SCCs and ADCs.


Esophageal Cancer Esophageal Carcinoma Advanced Carcinoma EGFR Amplification Oncogene Amplification 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jizuka T, Isono K, Kakegawa T, et al (1989) Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Chest 96:1005–1011CrossRefGoogle Scholar
  2. 2.
    Hermanek P (1995) pTNM and residual tumor classifications: problems of assessment and prognostic significance. World J Surg 19:184–190PubMedCrossRefGoogle Scholar
  3. 3.
    Lewin KJ, Appelman HD (1995) Tumors of the esophagus and stomach, third series, fascicle 18. Armed Forces Institute of Pathology, Washington, DCGoogle Scholar
  4. 4.
    Hölscher AH, Bollschweiler E, Schröder W (1997) Prognostic differences between early squamous-cell and adenocarcinoma of the esophagus. Dis Esophagus 10:179–184PubMedGoogle Scholar
  5. 5.
    World Health Organisation (1990) Histological typing of oesophageal and gastric tumors, 2nd edn. Berlin, SpringerGoogle Scholar
  6. 6.
    Sobin LH, Wittekind CH (1997) TNM classification of malignant tumors, 5th edn. Wiley-Liss, New YorkGoogle Scholar
  7. 7.
    Schwab M, Alitalo K, Klempnauer KH (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature 305:245–248PubMedCrossRefGoogle Scholar
  8. 8.
    Yamamoto T, Kamata N, Kawano H (1986) High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res 46:414–416PubMedGoogle Scholar
  9. 9.
    An H, Niederacher D, Beckmann MW, et al (1995) ErbB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast carcinoma tissues. Int J Cancer 64:291–297PubMedCrossRefGoogle Scholar
  10. 10.
    Sarbia M, Loberg C, Wolter M (1999) Expression of Bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus. Am J Pathol 155:1027–1032PubMedCrossRefGoogle Scholar
  11. 11.
    Montesano R, Hainaut P (1998) Molecular precursor lesions in oesophageal cancer. Cancer Surv 32:53–68PubMedGoogle Scholar
  12. 12.
    Natsugoe S, Nakashima S, Kijima F, et al (1999) Analysis of macroscopic appearance and p53 expression in superficial esophageal carcinoma. Hepatogastroenterology 46:1398–2404Google Scholar
  13. 13.
    Al-Kasspooles M, Moore JH, Orringer MB, et al (1993) Amplification and over-expression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas. Int J Cancer 54:213–219PubMedCrossRefGoogle Scholar
  14. 14.
    Chiang P-W, Beer DG, Wei W-L, et al (1999) Detection of c-erbB-2 amplifications in tumors and sera from esophageal carcinoma patients. Clin Cancer Res 5:1381–1386PubMedGoogle Scholar

Copyright information

© Springer Japan 2002

Authors and Affiliations

  • Mario Sarbia
    • 1
  1. 1.Department of PathologyUniversity of DüsseldorfDüsseldorfGermany

Personalised recommendations